Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae

J Rodríguez-Baño, B Gutiérrez-Gutiérrez… - Clinical microbiology …, 2018 - Am Soc Microbiol
Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is
challenging, and some of the few active drugs are not available in many countries. For …

Treatment of infections caused by multidrug-resistant gram-negative bacteria: Report of the British society for antimicrobial chemotherapy/healthcare infection society …

PM Hawkey, RE Warren, DM Livermore… - Journal of …, 2018 - academic.oup.com
Abstract The Working Party makes more than 100 tabulated recommendations in
antimicrobial prescribing for the treatment of infections caused by multidrug-resistant (MDR) …

[HTML][HTML] Current options for the treatment of infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in different groups of patients

B Gutiérrez-Gutiérrez, J Rodríguez-Baño - Clinical Microbiology and …, 2019 - Elsevier
Background Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) are a
frequent cause of invasive infections worldwide. Carbapenems are nowadays the most used …

Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–Review of the literature from a clinical …

LM Biehl, M Schmidt-Hieber, B Liss… - Critical reviews in …, 2016 - Taylor & Francis
Background: The prevalence of extended-spectrum β-lactamase producing
Enterobacteriaceae (ESBL-E) is increasing worldwide. ESBL-E are known to colonize …

Multidrug‐resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin‐resistant Enterococcus: Three major threats to hematopoietic stem cell …

MJ Satlin, TJ Walsh - Transplant Infectious Disease, 2017 - Wiley Online Library
Hematopoietic stem cell transplant (HSCT) recipients are uniquely threatened by the
emergence of multidrug‐resistant (MDR) bacteria because these patients rely on immediate …

Existence of Multiple ESBL Genes among Phenotypically Confirmed ESBL Producing Klebsiella pneumoniae and Escherichia coli Concurrently Isolated from …

V Silago, D Kovacs, H Samson, J Seni, L Matthews… - Antibiotics, 2021 - mdpi.com
The proportions and similarities of extended-spectrum β-lactamase (ESBL) producing K.
pneumoniae (ESBL-KP) and E. coli (ESBL-EC) carrying multiple ESBL genes is poorly …

[HTML][HTML] In vitro antimicrobial activity of five essential oils on multidrug resistant Gram-negative clinical isolates

H Sakkas, P Gousia, V Economou… - Journal of …, 2016 - ncbi.nlm.nih.gov
Materials and Methods: Basil, chamomile blue, origanum, thyme, and tea tree oil were tested
against clinical isolates of Acinetobacter baumannii (n= 6), Escherichia coli (n= 4), Klebsiella …

In silico study for Algerian essential oils as antimicrobial agents against multidrug-resistant bacteria isolated from pus samples

A Aouf, S Bouaouina, MA Abdelgawad… - Antibiotics, 2022 - mdpi.com
In the context of the globally growing problem of resistance to most used antibacterial
agents, essential oils offer promising solutions against multidrug-resistant (MDR) bacterial …

Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from …

NA El Aila, NA Al Laham, BM Ayesh - BMC Infectious Diseases, 2023 - Springer
Background Extended-spectrum β lactamases (ESBLs), have the ability to hydrolyze and
cause resistance to various types of the β-lactam antibiotics, including the extended …

Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects

CC Sheu, SY Lin, YT Chang, CY Lee… - Expert review of anti …, 2018 - Taylor & Francis
Introduction: The spread of extended-spectrum β–lactamase (ESBL)-producing
Enterobacteriaceae has become a major public health threat worldwide. Area covered: A …